Filter News
Area of Research
News Topics
- (-) Artificial Intelligence (1)
- (-) Biomedical (1)
- (-) Environment (4)
- (-) Machine Learning (1)
- (-) Materials Science (2)
- 3-D Printing/Advanced Manufacturing (7)
- Bioenergy (5)
- Clean Water (2)
- Composites (1)
- Computer Science (1)
- Cybersecurity (1)
- Grid (1)
- Mercury (1)
- Neutron Science (6)
- Physics (1)
- Security (1)
- Sustainable Energy (5)
- Transportation (4)
Media Contacts
An international team of scientists, led by the University of Manchester, has developed a metal-organic framework, or MOF, material
Elizabeth Herndon believes in going the distance whether she is preparing to compete in the 2020 Olympic marathon trials or examining how metals move through the environment as a geochemist at the Department of Energy’s Oak Ridge National Laboratory.
ORNL and The University of Toledo have entered into a memorandum of understanding for collaborative research.
The National Alliance for Water Innovation, a partnership of the Department of Energy’s Oak Ridge National Laboratory, other national labs, university and private sector partners, has been awarded a five-year, $100 million Energy-Water Desalination Hub by DOE to address water security issues in the United States.
Quanex Building Products has signed a non-exclusive agreement to license a method to produce insulating material from ORNL. The low-cost material can be used as an additive to increase thermal insulation performance and improve energy efficiency when applied to a variety of building products.
Electro-Active Technologies, Inc., of Knoxville, Tenn., has exclusively licensed two biorefinery technologies invented and patented by the startup’s co-founders while working at the Department of Energy’s Oak Ridge National Laboratory. The technologies work as a system that converts organic waste into renewable hydrogen gas for use as a biofuel.
IDEMIA Identity & Security USA has licensed an advanced optical array developed at Oak Ridge National Laboratory. The portable technology can be used to help identify individuals in challenging outdoor conditions.
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.